Home › Chronic-Phase Myeloid Leukemia › North Carolina
Chronic-Phase Myeloid Leukemia clinical trials in North Carolina
3 studies for Chronic-Phase Myeloid Leukemia are looking for participants at sites in North Carolina.
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1019, Greenville
- Ascentage Investigative Site #1043, Morrisville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06423911Registry of Older Patients With Cancer
- Seby B. Jones Cancer Center, Boone
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill
- East Carolina University, Greenville
- and 4 more
RecruitingObservational study
Ages 65 and older · All sexes · Updated Jun 29, 2026 · NCT01137825A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Atrium Health Levine Cancer Institute, Winston-Salem
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jan 12, 2026 · NCT06163430From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.